In its 23rd year, Discovery on Target is the premier event highlighting “hot” drug targets and emerging modalities, technologies, and strategies for pursuing those targets. The numerous conferences, symposia, courses, and training seminars offer key insights for the successful discovery and development of novel therapeutics, from small molecules to biologics to chimeras and conjugates. The 4 day event covers innovations in target identification and lead generation, which includes cancer therapies, protein degradation, induced proximity, AI/machine learning, membrane proteins, translational models, synthetic biology, and other relevant topics. New this year is an increased coverage of GLP-1, MASH and obesity, ADCs, and bispecifics and small molecules targeting DNA.
This event offers a unique opportunity to engage in meaningful conversations and foster connections with a global audience of 1100+ drug discovery experts. Concurrent sessions with over 220 presentations, 110+ posters, panels, breakout discussions, and 1-1 networking events enable you to customize your on-site experience and engage with problem-solvers and solutions providers who can be future collaborators. Join our growing DOT community to be at the forefront of new ideas and trends in drug discovery. We look forward to welcoming you in Boston!